Stock ScreenerStock IdeasZen Ratings + Top Analysts
Stocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Jul 7, 2025
The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.

Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
Ticker
Company
Zen Rating
Financials
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
BMRN
BIOMARIN PHARMACEUTICAL INC
AB$11.03B9.50%7.50%10.53%12.20%0.235.5279.40%17.80%23.26%
PEN
PENUMBRA INC
AB$9.72B3.60%2.80%3.49%4.50%0.316.3063.70%3.40%4.04%
PEGA
PEGASYSTEMS INC
AA$9.20B37.40%12.70%40.71%41.90%1.161.3975.70%12.00%17.67%
WIX
WIXCOM LTD
AA$9.15B-77.00%8.40%41.50%15.50%-11.710.7968.10%8.20%7.04%
BGC
BGC GROUP INC
AB$5.30B14.90%3.10%N/A6.60%3.88N/A100.00%5.70%12.05%
ACIW
ACI WORLDWIDE INC
AB$4.85B19.70%8.50%16.58%23.80%1.161.5051.30%16.10%23.77%
PTCT
PTC THERAPEUTICS INC
AA$3.89B-71.70%29.30%39.40%123.50%-15.303.8996.90%33.60%45.78%
BTSG
BRIGHTSPRING HEALTH SERVICES INC
AC$3.85B3.50%1.00%6.18%6.90%2.461.7413.50%0.50%2.34%
ENS
ENERSYS
AB$3.54B19.60%9.40%14.32%16.20%1.072.7030.20%10.10%12.65%
AMRX
AMNEAL PHARMACEUTICALS INC
AC$2.64BN/A-0.40%11.46%7.40%-26.561.4036.70%-0.50%9.27%
CPRX
CATALYST PHARMACEUTICALS INC
AA$2.62B28.30%24.40%32.42%400.20%0.146.1486.10%36.90%48.34%
ARDT
ARDENT HEALTH PARTNERS INC
AB$1.92B22.20%4.70%8.65%7.40%2.852.1217.40%3.70%5.86%
CINT
CI&T INC
AB$816.90MN/AN/AN/AN/AN/AN/A33.90%7.20%17.17%
DLX
DELUXE CORP
AB$767.29M9.00%2.10%9.32%10.20%3.140.9352.90%2.60%9.56%
HRTG
HERITAGE INSURANCE HOLDINGS INC
AC$714.39M27.00%3.20%N/A5.60%5.73N/A46.90%9.30%13.54%
LYTS
LSI INDUSTRIES INC
AC$535.58M10.20%6.10%10.97%16.40%0.742.0824.70%4.00%5.92%
QUAD
QUAD/GRAPHICS INC
AC$294.56M-25.40%-1.30%6.97%4.40%13.260.9621.80%-0.60%1.88%
MAPS
WM TECHNOLOGY INC
AA$142.02M23.20%4.60%5.34%13.90%1.242.2495.20%4.40%4.38%

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have a premium account? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.